Raymond James Financial Services Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $64M | Sell |
1,017,467
-181,687
| -15% | -$10.6M | 0.09% | 229 |
|
|
2024
Q2 | $70.8M | Sell |
1,199,154
-321,037
| -21% | -$20.1M | 0.1% | 192 |
|
|
2024
Q1 | $121M | Sell |
1,520,191
-32,854
| -2% | -$2.51M | 0.18% | 112 |
|
|
2023
Q4 | $123M | Sell |
1,553,045
-57,882
| -4% | -$4.12M | 0.2% | 106 |
|
|
2023
Q3 | $112M | Sell |
1,610,927
-58,532
| -4% | -$4.15M | 0.2% | 107 |
|
|
2023
Q2 | $115M | Buy |
1,669,459
+69,112
| +4% | +$4.92M | 0.2% | 103 |
|
|
2023
Q1 | $119M | Sell |
1,600,347
-59,379
| -4% | -$4.98M | 0.23% | 89 |
|
|
2022
Q4 | $155M | Sell |
1,659,726
-39,712
| -2% | -$3.83M | 0.31% | 70 |
|
|
2022
Q3 | $162M | Buy |
1,699,438
+17,216
| +1% | +$1.7M | 0.36% | 56 |
|
|
2022
Q2 | $156M | Sell |
1,682,222
-61,302
| -4% | -$5.98M | 0.34% | 63 |
|
|
2022
Q1 | $176M | Sell |
1,743,524
-122,789
| -7% | -$12.9M | 0.33% | 66 |
|
|
2021
Q4 | $193M | Sell |
1,866,313
-102,327
| -5% | -$9.46M | 0.36% | 60 |
|
|
2021
Q3 | $167M | Sell |
1,968,640
-73,499
| -4% | -$6.16M | 0.34% | 60 |
|
|
2021
Q2 | $170M | Sell |
2,042,139
-87,845
| -4% | -$7.19M | 0.35% | 58 |
|
|
2021
Q1 | $160M | Buy |
2,129,984
+55,725
| +3% | +$4.06M | 0.36% | 57 |
|
|
2020
Q4 | $142M | Sell |
2,074,259
-54,465
| -3% | -$3.54M | 0.35% | 59 |
|
|
2020
Q3 | $124M | Sell |
2,128,724
-331,789
| -13% | -$20.6M | 0.35% | 56 |
|
|
2020
Q2 | $160M | Buy |
2,460,513
+227,444
| +10% | +$14.3M | 0.51% | 34 |
|
|
2020
Q1 | $132M | Buy |
2,233,069
+238,951
| +12% | +$16M | 0.58% | 33 |
|
|
2019
Q4 | $148M | Buy |
1,994,118
+135,932
| +7% | +$9.54M | 0.47% | 39 |
|
|
2019
Q3 | $117M | Buy |
1,858,186
+147,688
| +9% | +$8.75M | 0.43% | 47 |
|
|
2019
Q2 | $93.2M | Buy |
1,710,498
+201,039
| +13% | +$10.8M | 0.36% | 57 |
|
|
2019
Q1 | $81.4M | Buy |
1,509,459
+291,100
| +24% | +$18M | 0.34% | 58 |
|
|
2018
Q4 | $79.8M | Buy |
1,218,359
+301,775
| +33% | +$22.5M | 0.42% | 41 |
|
|
2018
Q3 | $72.2M | Buy |
916,584
+74,324
| +9% | +$5.31M | 0.33% | 58 |
|
|
2018
Q2 | $54.2M | Buy |
842,260
+252,116
| +43% | +$16.6M | 0.28% | 75 |
|
|
2018
Q1 | $36.7M | Buy |
590,144
+150,595
| +34% | +$10.8M | 0.21% | 106 |
|
|
2017
Q4 | $31.9M | Sell |
439,549
-14,800
| -3% | -$1.08M | 0.2% | 111 |
|
|
2017
Q3 | $36.9M | Buy |
454,349
+34,546
| +8% | +$2.73M | 0.24% | 92 |
|
|
2017
Q2 | $33.8M | Buy |
419,803
+13,611
| +3% | +$1.07M | 0.23% | 91 |
|
|
2017
Q1 | $31.9M | Buy |
406,192
+54,521
| +16% | +$4.35M | 0.24% | 88 |
|
|
2016
Q4 | $27.8M | Buy |
351,671
+9,937
| +3% | +$804K | 0.23% | 98 |
|
|
2016
Q3 | $30.4M | Buy |
341,734
+13,317
| +4% | +$1.26M | 0.27% | 80 |
|
|
2016
Q2 | $31.4M | Buy |
328,417
+30,776
| +10% | +$3.07M | 0.3% | 67 |
|
|
2016
Q1 | $30.9M | Buy |
297,641
+50,818
| +21% | +$4.94M | 0.36% | 56 |
|
|
2015
Q4 | $24.1M | Buy |
246,823
+48,421
| +24% | +$4.74M | 0.28% | 81 |
|
|
2015
Q3 | $19.1M | Buy |
198,402
+146,365
| +281% | +$15.4M | 0.32% | 70 |
|
|
2015
Q2 | $5.46M | Buy |
52,037
+17,244
| +50% | +$1.76M | 0.39% | 59 |
|
|
2015
Q1 | $3.59M | Sell |
34,793
-839
| -2% | -$84.9K | 0.18% | 148 |
|
|
2014
Q4 | $3.43M | Buy |
35,632
+5,261
| +17% | +$464K | 0.18% | 145 |
|
|
2014
Q3 | $2.42M | Sell |
30,371
-1,390
| -4% | -$110K | 0.13% | 193 |
|
|
2014
Q2 | $2.39M | Sell |
31,761
-1,000
| -3% | -$75.6K | 0.14% | 181 |
|
|
2014
Q1 | $2.45M | Sell |
32,761
-1,929
| -6% | -$136K | 0.14% | 184 |
|
|
2013
Q4 | $2.48M | Sell |
34,690
-1,612
| -4% | -$104K | 0.15% | 170 |
|
|
2013
Q3 | $2.06M | Sell |
36,302
-101,219
| -74% | -$6.03M | 0.14% | 191 |
|
|
2013
Q2 | $7.86M | Buy |
+137,521
| New | +$7.97M | 0.23% | 97 |
|
Other funds holding CVS
Raymond James Financial Services Advisors's CVS Position: Q3 2024 in Review
Raymond James Financial Services Advisors reduced its CVS Health (CVS) stake by 15% in Q3 2024, selling an estimated $10.6M and leaving 1,017,467 shares worth $64M. The position accounts for 0.09% of the portfolio, ranked #229.
Raymond James Financial Services Advisors first reported a position in CVS in Q2 2013 and has held it in 46 quarters since. The position peaked at $193M in Q4 2021. 1,841 funds tracked by Wall St. Rank hold CVS as of Q3 2024.
- Raymond James Financial Services Advisors held 1,017,467 shares of CVS Health worth $64M as of Q3 2024.
- Raymond James Financial Services Advisors sold 181,687 CVS Health shares in Q3 2024, an estimated $10.6M.
- CVS Health made up 0.09% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #229 holding.
- Raymond James Financial Services Advisors first reported a position in CVS Health in Q2 2013 and has held it in 46 quarters since.
- Raymond James Financial Services Advisors's CVS Health position peaked at $193M in Q4 2021.
- 1,841 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.
Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.